Wakeful EEG Dynamics Track Serum Lithium in Toxicity Case Report

Wakeful scalp EEG changes correlated with serum lithium concentration before and after treatment of lithium carbonate toxicity, according to a case report and literature review published ahead of print in Clinical EEG and Neuroscience.

Lithium carbonate remains a first-line psychopharmacological agent for mood disorders. The authors note its significant therapeutic and prophylactic efficacy in managing bipolar affective disorder and preventing relapse. That efficacy carries a narrow margin: toxicity can occur, and the new report examines how the electroencephalogram behaves across the course of one such episode.

What did the study examine?

The investigators recorded wakeful scalp EEG in a single patient during lithium carbonate toxicity, then again after treatment lowered the serum lithium concentration. They compared the EEG dynamics against the measured serum lithium values across both phases and reviewed the prior literature on lithium-related EEG findings.

The design is a case report, not a controlled trial. No device specifications, cohort size beyond the single patient, or montage details appear in the ahead-of-print abstract. Readers should treat the correlation as an observation in one documented toxicity course, supported by a literature review rather than by group-level statistics.

Why the finding matters for the reading room

Serum lithium assays guide toxicity management today, but they do not describe central nervous system effects in real time. If serial wakeful EEG changes track the serum concentration, as this case suggests, the scalp record could offer a bedside correlate of neural recovery during treatment.

For clinical neurophysiologists, the practical implication is concrete: EEG studies obtained in psychiatric patients on lithium deserve scrutiny against the dosing and laboratory timeline. Slowing or other dynamic changes on the wakeful record may reflect rising or falling lithium levels rather than an unrelated encephalopathy alone.

What the report does not establish

The evidence is investigational and observational. A single case cannot define sensitivity, specificity, or the latency between serum change and EEG change. The authors ground their argument in a literature review of prior reports, which strengthens face validity but does not replace prospective serial recordings in a defined cohort.

The work has not produced, and does not claim, a validated EEG-based monitoring tool. It documents a correlation worth testing.

Future prospective studies with serial scalp EEG and paired serum lithium measurements could determine whether the electroencephalogram serves as a reliable clinical surrogate during lithium toxicity treatment.